related documents
- COST-EFFECTIVENESS OF SABR IN OLIGOMETASTATIC CANCER: AN ECONOMIC ANALYSIS BASED ON LONG-TERM RESULTS OF THE SABR-COMET RANDOMIZED TRIAL Conferences
- REAL-WORLD OUTCOMES OF CHEMORADIATION AND CONSOLIDATIVE DURVALUMAB IN UNRESECTABLE STAGE III NON-SMALL-CELL LUNG CANCER - A SYSTEMATIC REVIEW Conferences